Download CAC

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Overexpression of MMP9 in colonic
epithelium mediates protection in colitis
associated cancer
PALLAVI GARG
Ph.D.
Disclosures
Nothing to Disclose
Matrix Metalloproteinases (MMPs)
Are a family of zinc-dependent proteolytic
enzymes with the ability to degrade
extracellular matrix substrates such as
collagen, gelatin and proteoglycans
Colitis Associated Cancer (CAC) &
Colorectal Cancer
•
•
•
•
•
CAC is an important complication of Ulcerative Colitis or colonic
Crohn’s Disease that results in significant morbidity and mortality
It causes 1/6 of all deaths in patients with ulcerative colitis
Colon cancer develops in flat dysplastic tissue among IBD
individuals
CAC is often multiple, anaplastic, broadly infiltrating, rapidly
growing and occurs at a younger age
The pathogenesis of CAC is not known
MMP9 and its role in acute colitis
•
•
MMP9 is not expressed in normal tissues and is one of the
predominant MMPs that is up-regulated in several animal
models of colitis and human IBD
MMP9 mRNA and protein levels are increased in the inflamed
colonic mucosa of patients with IBD
•
MMP9 activity correlates with active inflammation
•
MMP9 activates Notch1 signaling in colonic epithelium
Castaneda et al, 2005, Gastroenterology
Garg et al, 2007, Gastroenterology
Role of MMP9 in CAC
• MMP9-/- mice show increased susceptibility to CAC
• CAC in MMP9-/- mice is associated with decreased apoptosis
compared to WT mice
• CAC in MMP9-/- mice showed decreased levels of p21WAF1/Cip1
and p53
• MMP9 mediates its tumor suppressive role via activation of
Notch1 signaling
Garg et al, 2010, Cancer Research
Garg et al, 2011, Gastroenterology
Aim
Which MMP9 protects from CAC ?
In vivo model
C57/B6
WT
Water
DSS (3 cycles)
Tg-villin-MMP9
Water
DSS= Dextran Sodium Sulfate (3% in drinking water)
DSS (3 cycles)
In vivo protocol
Days
0
7
14
28
35
49
53
DSS Cycle
DSS Cycle
DSS Cycle
(3rd ) starts
(1st) starts
(2nd ) starts
Recovery
Recovery
Recovery
st
(1 ) starts
(2nd) starts
(3rd) starts
85
sacrifice
Body weight gain
in percentage
Overexpression of epithelial MMP9
exhibited resistance to CAC
*
*
*
1
2
*
3
Tg-villin-MMP9
WT
Sacrifice
DSS
DSS
DSS
cycle 2
cycle 3
cycle 1
Recovery
Recovery
Recovery
cycle 2
cycle 3
cycle 1
Overexpression of epithelial MMP9
exhibited less tumor incidence in CAC
B
Number of polyps
Number of dysplastic lesions
A
WT
CAC
Tg-villin-MMP9
CAC
*
WT
CAC
Tg-villin-MMP9
CAC
Overexpression of epithelial MMP9
exhibited resistance to CAC
X10
WT CAC
Tg-villinMMP9 CAC
X20
Overexpression of epithelial MMP9
showed increased levels of Notch1and p53
in CAC A
Tg-villinMMP9, CAC
WT, CAC
MMP9, 104 kD
β-tubulin
1
2
3
4
5
6
Tg-villinMMP9, CAC
WT, CAC
B
NICD, 80 kD
β-tubulin
1
2
3
4
5
6
Tg-villinMMP9, CAC
WT, CAC
C
p53, 53 kD
GAPDH
1
2
3
4
5
6
Overexpression of epithelial MMP9
showed increased levels of p21WAF1/Cip1and
Bax1 in CAC
A
Tg-villinMMP9, CAC
WT, CAC
p21WAF1/Cip1, 21kD
GAPDH
1
B
2
3
4
5
6
Tg-villinWT, CAC MMP9, CAC
Bax-1, 37 kD
GAPDH
1
2
3
4
5
6
Overexpression of MMP9 in MMP9-/- MEFs
showed increased levels of Notch1 and p53
MMP9-/MEFs
WT
MEFs
MMP9-/-MEFs
+ MMP9
A
MMP-9, 104 kD
B
NICD, 80 kD
GAPDH
1
2
MMP9-/MEFs
3
4
5
WT
MEFs
6
MMP9-/-MEFs
+ MMP9
C
p53, 53 kD
GAPDH
1
2
3
4
5
6
Summary
•Epithelial-derived MMP9 plays a tumor suppressive role
in CAC
• Overexpression of MMP9 in colonic epithelium is associated
with altered levels of p53, Notch1, Bax1 and p21WAF1/Cip1
• Overexpression of MMP9 in MMP9
of NICD and p53
-/-exhibited
increased levels
Molecular mechanism of p53 regulation by
MMP9 via Notch1
Inflammation
nucleus
ARF
+
+
+
Mdm2
ARF
Notch-1
Mdm2
Mdm2
+
p53
cytosol
+
MMP-9
Conclusions
• Despite being a mediator of acute inflammation,
epithelial derived- MMP9 acts as a tumor suppressor
in CAC
• MMP9 mediated p53 activation via Notch1 signaling
is necessary and sufficient for its tumor suppressive
effect in CAC
Acknowledgement
Didier Merlin
Lewins Walter
Crohn’s & Colitis Foundation of America
Career Development Award, (#3057)